ReviewPulmonary medicine2021

The Role of ICS/LABA Fixed-Dose Combinations in the Treatment of Asthma and COPD: Bioequivalence of a Generic Fluticasone Propionate-Salmeterol Device.

Donald P Tashkin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.